Applied Therapeutics is a biotechnology business based in the US. Applied Therapeutics shares (APLT) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $8.93 – a decrease of 0.89% over the previous week. Applied Therapeutics employs 37 staff and has a market cap (total outstanding shares value) of 0.00.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $8.93 |
|---|---|
| 52-week range | $1.79 - $10.62 |
| 50-day moving average | $8.06 |
| 200-day moving average | $5.89 |
| Wall St. target price | $14.67 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-1.42 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $8.93 from 2024-11-19
| 1 week (2024-11-13) | 0.11% |
|---|---|
| 1 month (2024-10-18) | -0.33% |
| 3 months (2024-08-20) | 51.61% |
| 6 months (2024-05-20) | 112.62% |
| 1 year (2023-11-20) | 348.74% |
|---|---|
| 2 years (2022-11-18) | 954.31% |
| 3 years (2021-11-19) | 11.92 |
| 5 years (2019-11-20) | 16.6 |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -76.01% |
| Return on equity TTM | -473.39% |
| Profit margin | 0% |
| Book value | $0.05 |
| Market Capitalization | $1 billion |
TTM: trailing 12 months
We're not expecting Applied Therapeutics to pay a dividend over the next 12 months.
Over the last 12 months, Applied Therapeutics's shares have ranged in value from as little as $1.79 up to $10.6237. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied Therapeutics's is 2.018. This would suggest that Applied Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 (also called govorestat) that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It also develops AT-001 (also called caficrestat) that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.